Cargando…
Women at high risk of HIV-infection in Kampala, Uganda, and their candidacy for PrEP
Pre-exposure prophylaxis (PrEP), antiretroviral medication for prevention of HIV-acquisition, is part of biomedical HIV prevention strategies recommended for people at risk of HIV-infection. A decision to take PrEP depends on an assessment of ‘being at risk’ either by an individual, or healthcare pr...
Autores principales: | Kawuma, Rachel, Ssemata, Andrew Sentoogo, Bernays, Sarah, Seeley, Janet |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7873676/ https://www.ncbi.nlm.nih.gov/pubmed/33604448 http://dx.doi.org/10.1016/j.ssmph.2021.100746 |
Ejemplares similares
-
Assessing acceptability of pre-exposure prophylaxis (PrEP) among participants in an HIV vaccine preparedness study in southwestern Uganda
por: Nakamanya, Sarah, et al.
Publicado: (2022) -
Feasibility and acceptability of peer-delivered HIV self-testing and PrEP for young women in Kampala, Uganda
por: Nakalega, Rita, et al.
Publicado: (2023) -
PrEP uptake and persistence amongst HIV-negative women who exchange sex for money or commodities in Kampala, Uganda: A qualitative inquiry assessing the influence of pregnancy
por: Joshi, Shivali, et al.
Publicado: (2023) -
Exploring Perceived Barriers and Facilitators of PrEP Uptake among Young People in Uganda, Zimbabwe, and South Africa
por: Muhumuza, Richard, et al.
Publicado: (2021) -
Examining oral pre-exposure prophylaxis (PrEP) literacy among participants in an HIV vaccine trial preparedness cohort study
por: Chimukuche, Rujeko Samanthia, et al.
Publicado: (2022)